 | • レポートコード：TMR2008013 • 出版社/出版日：Transparency Market Research / 2020年6月 • レポート形態：英文、PDF、173ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、アルコール性肝炎治療の世界市場について調査・分析し、序文、仮定・調査手法、エグゼクティブサマリー、市場概要、市場分析・予測、市場見通し、治療別（コルチコステロイド、血液レオロジー剤、同化ステロイドホルモン、その他）分析、用途別（軽度、重度/慢性）分析、流通チャンネル別（病院薬局、小売薬局、オンライン薬局）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを含め、以下の構成でご提供いたします。 ・序文 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・市場分析・予測 ・市場見通し ・アルコール性肝炎治療の世界市場：治療別（コルチコステロイド、血液レオロジー剤、同化ステロイドホルモン、その他） ・アルコール性肝炎治療の世界市場：用途別（軽度、重度/慢性） ・アルコール性肝炎治療の世界市場：流通チャンネル別（病院薬局、小売薬局、オンライン薬局） ・アルコール性肝炎治療の世界市場：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Alcoholic Hepatitis Therapeutics Market – Scope of the Report
TMR’s report on the global alcoholic hepatitis therapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2020 to 2030. The report provides revenue of the global alcoholic hepatitis therapeutics market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global alcoholic hepatitis therapeutics market from 2020 to 2030.
The report is prepared after an extensive research. Primary research involves bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involved reaching out to key players’ product literature, annual reports, press releases, and relevant documents to understand the alcoholic hepatitis therapeutics market.
Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the alcoholic hepatitis therapeutics market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global alcoholic hepatitis therapeutics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global alcoholic hepatitis therapeutics market.
The report delves into the competition landscape of the global alcoholic hepatitis therapeutics market. Key players operating in the global alcoholic hepatitis therapeutics market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global alcoholic hepatitis therapeutics market profiled in this report.
Key Questions Answered in Alcoholic Hepatitis Therapeutics Market Report
What is the sales/revenue generated by alcoholic hepatitis therapeutics across all regions during the forecast period?
What are the opportunities in the global alcoholic hepatitis therapeutics market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which treatment segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Alcoholic Hepatitis Therapeutics Market – Research Objectives and Research Approach
The comprehensive report on the global alcoholic hepatitis therapeutics market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global alcoholic hepatitis therapeutics market in terms of treatment, application, distribution channel, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2030 has also been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global alcoholic hepatitis therapeutics market.
レポート目次1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Research Methodology
3. Executive Summary
3.1. Global Alcoholic Hepatitis Therapeutics Market Snapshot
4. Market Overview
4.1. Product Overview
4.2. Market Dynamics
4.3. Drivers and Restraints Snapshot Analysis
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Key Trends
4.4. Global Alcoholic Hepatitis Therapeutics Market Revenue Projection
4.5. Global Alcoholic Hepatitis Therapeutics Market Outlook
5. Market Outlook
5.1. COVID-19 Pandemic Impact on Global Alcoholic Hepatitis Therapeutics Industry
5.2. Regulatory Scenario, by Region/globally
5.3. Health Care Overview
5.4. Pipeline Analysis
5.5. Epidemiology of Alcoholic Liver Diseases
5.6. Overview of Alcoholic Hepatitis
6. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Treatment
6.1. Introduction
6.2. Global Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
6.3. Global Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
6.3.1. Corticosteroids
6.3.2. Hemorrheologic Agents
6.3.3. Anabolic Steroids
6.3.4. Others
6.4. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Treatment
7. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Application
7.1. Introduction
7.2. Global Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
7.3. Global Alcoholic Hepatitis Therapeutics Market Forecast, by Application
7.3.1. Mild
7.3.2. Severe/Chronic
7.4. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Application
8. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Distribution Channel
8.1. Introduction
8.2. Global Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
8.3. Global Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.4. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Distribution Channel
9. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Region
9.1. Global Alcoholic Hepatitis Therapeutics Market Scenario, by Country
9.2. Global Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Region
9.3. Global Alcoholic Hepatitis Therapeutics Market Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
10. North America Alcoholic Hepatitis Therapeutics Market Analysis
10.1. North America Alcoholic Hepatitis Therapeutics Market Analysis
10.2. North America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
10.3. North America Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
10.3.1. Corticosteroids
10.3.2. Hemorrheologic Agents
10.3.3. Anabolic Steroids
10.3.4. Others
10.4. North America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
10.5. North America Alcoholic Hepatitis Therapeutics Market Forecast, by Application
10.5.1. Mild
10.5.2. Severe/Chronic
10.6. North America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
10.7. North America Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
10.7.1. Hospital Pharmacies
10.7.2. Retail Pharmacies
10.7.3. Online Pharmacies
10.8. North America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country
10.9. North America Alcoholic Hepatitis Therapeutics Market Forecast, by Country
10.9.1. U.S.
10.9.2. Canada
11. Europe Alcoholic Hepatitis Therapeutics Market Analysis
11.1. Europe Alcoholic Hepatitis Therapeutics Market Analysis
11.2. Europe Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
11.3. Europe Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
11.3.1. Corticosteroids
11.3.2. Hemorrheologic Agents
11.3.3. Anabolic Steroids
11.3.4. Others
11.4. Europe Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
11.5. Europe Alcoholic Hepatitis Therapeutics Market Forecast, by Application
11.5.1. Mild
11.5.2. Severe/Chronic
11.6. Europe Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
11.7. Europe Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
11.7.1. Hospital Pharmacies
11.7.2. Retail Pharmacies
11.7.3. Online Pharmacies
11.8. Europe Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.9. Europe Alcoholic Hepatitis Therapeutics Market Forecast, by Country/Sub-region
11.9.1. U.K.
11.9.2. Germany
11.9.3. France
11.9.4. Spain
11.9.5. Italy
11.9.6. Rest of Europe
12. Asia Pacific Alcoholic Hepatitis Therapeutics Market Analysis
12.1. Asia Pacific Alcoholic Hepatitis Therapeutics Market Analysis
12.2. Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
12.3. Asia Pacific Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
12.3.1. Corticosteroids
12.3.2. Hemorrheologic Agents
12.3.3. Anabolic Steroids
12.3.4. Others
12.4. Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
12.5. Asia Pacific Alcoholic Hepatitis Therapeutics Market Forecast, by Application
12.5.1. Mild
12.5.2. Severe/Chronic
12.6. Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
12.7. Asia Pacific Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
12.7.1. Hospital Pharmacies
12.7.2. Retail Pharmacies
12.7.3. Online Pharmacies
12.8. Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.9. Asia Pacific Alcoholic Hepatitis Therapeutics Market Forecast, by Country/Sub-region
12.9.1. Australia & New Zealand
12.9.2. Japan
12.9.3. China
12.9.4. India
12.9.5. Rest of Asia Pacific
13. Latin America Alcoholic Hepatitis Therapeutics Market Analysis
13.1. Latin America Alcoholic Hepatitis Therapeutics Market Analysis
13.2. Latin America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
13.3. Latin America Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
13.3.1. Corticosteroids
13.3.2. Hemorrheologic Agents
13.3.3. Anabolic Steroids
13.3.4. Others
13.4. Latin America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
13.5. Latin America Alcoholic Hepatitis Therapeutics Market Forecast, by Application
13.5.1. Mild
13.5.2. Severe/Chronic
13.6. Latin America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
13.7. Latin America Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
13.7.1. Hospital Pharmacies
13.7.2. Retail Pharmacies
13.7.3. Online Pharmacies
13.8. Latin America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.9. Latin America Alcoholic Hepatitis Therapeutics Market Forecast, by Country/Sub-region
13.9.1. Brazil
13.9.2. Mexico
13.9.3. Rest of Latin America
14. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Analysis
14.1. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Analysis
14.2. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
14.3. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
14.3.1. Corticosteroids
14.3.2. Hemorrheologic Agents
14.3.3. Anabolic Steroids
14.3.4. Others
14.4. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
14.5. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Forecast, by Application
14.5.1. Mild
14.5.2. Severe/Chronic
14.6. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
14.7. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
14.7.1. Hospital Pharmacies
14.7.2. Retail Pharmacies
14.7.3. Online Pharmacies
14.8. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region
14.9. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Forecast, by Country/Sub-region
14.9.1. GCC Countries
14.9.2. South Africa
14.9.3. Rest of Middle East & Africa
15. Competitive Landscape
15.1. Company Profile
15.1.1. Gilead Sciences, Inc.
15.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.1.1.2. Financial Overview
15.1.1.3. Product Portfolio
15.1.1.4. SWOT Analysis
15.1.1.5. Strategic Overview
15.1.2. Sanofi
15.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.1.2.2. Financial Overview
15.1.2.3. Product Portfolio
15.1.2.4. SWOT Analysis
15.1.2.5. Strategic Overview
15.1.3. Generon Pharmaceutical Technology (Shanghai) Co., Ltd.
15.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.1.3.2. Financial Overview
15.1.3.3. Product Portfolio
15.1.3.4. SWOT Analysis
15.1.3.5. Strategic Overview
15.1.4. Immuron Ltd.
15.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.1.4.2. Product Portfolio
15.1.4.3. SWOT Analysis
15.1.4.4. Strategic Overview
15.1.5. Intercept Pharmaceuticals, Inc.
15.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.1.5.2. Financial Overview
15.1.5.3. Product Portfolio
15.1.5.4. SWOT Analysis
15.1.5.5. Strategic Overview
List of TablesTable 01: Alcohol, total per capita (15+) consumption (in liters of pure alcohol) with 95%CI, by Country, 2016
Table 02: Epidemiology of Covid-19 Country/Sub-region
Table 03: Gross Domestic Product (GDP), by Country, 2014-2017
Table 04: Pipeline Analysis of Alcoholic Hepatitis Therapeutics
Table 05: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2018–2030
Table 06: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 07: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 08: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 09: North America Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Treatment, 2018–2030
Table 10: North America Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Application, 2018–2030
Table 11: North America Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 12: North America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 13: Europe Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) Forecast, by Treatment, 2018–2030
Table 14: Europe Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) Forecast, by Application, 2018–2030
Table 15: Europe Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 16: Europe Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 17: Asia Pacific Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Treatment, 2018–2030
Table 18: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 19: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 20: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 21: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2018–2030
Table 22: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 23: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 24: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 25: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2018–2030
Table 26: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 27: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 28: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030